These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25383714)

  • 1. A physiologically-motivated compartment-based model of the effect of inhaled hypertonic saline on mucociliary clearance and liquid transport in cystic fibrosis.
    Markovetz MR; Corcoran TE; Locke LW; Myerburg MM; Pilewski JM; Parker RS
    PLoS One; 2014; 9(11):e111972. PubMed ID: 25383714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
    N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.
    Laube BL; Sharpless G; Carson KA; Kelly A; Mogayzel PJ
    BMC Pulm Med; 2011 Sep; 11():45. PubMed ID: 21896198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE; Godovchik JE; Donn KH; Busick DR; Goralski J; Locke LW; Markovetz MR; Myerburg MM; Muthukrishnan A; Weber L; Lacy RT; Pilewski JM
    Pediatr Pulmonol; 2017 Sep; 52(9):1142-1149. PubMed ID: 28737262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiprobe Nuclear Imaging of the Cystic Fibrosis Lung as a Biomarker of Therapeutic Effect.
    Corcoran TE; Huber AS; Myerburg MM; Weiner DJ; Locke LW; Lacy RT; Weber L; Czachowski MR; Johnston DJ; Muthukrishnan A; Lennox AT; Pilewski JM
    J Aerosol Med Pulm Drug Deliv; 2019 Aug; 32(4):242-249. PubMed ID: 30969149
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis.
    Trimble AT; Whitney Brown A; Laube BL; Lechtzin N; Zeman KL; Wu J; Ceppe A; Waltz D; Bennett WD; Donaldson SH
    J Cyst Fibros; 2018 Sep; 17(5):650-656. PubMed ID: 29371133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008816. PubMed ID: 32107770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Hemming AL; Regnis JA; Wong AG; Bailey DL; Bautovich GJ; King M; Bye PT
    Thorax; 1997 Oct; 52(10):900-3. PubMed ID: 9404379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmolytes and ion transport modulators: new strategies for airway surface rehydration.
    Goralski JL; Boucher RC; Button B
    Curr Opin Pharmacol; 2010 Jun; 10(3):294-9. PubMed ID: 20439165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
    Tarran R; Donaldson S; Boucher RC
    Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT
    Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008816. PubMed ID: 22336853
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Escher A; Kieninger E; Groof S; Savas ST; Schneiter M; Tschanz SA; Frenz M; Latzin P; Casaulta C; Müller L
    J Aerosol Med Pulm Drug Deliv; 2023 Aug; 36(4):171-180. PubMed ID: 37196208
    [No Abstract]   [Full Text] [Related]  

  • 15. A four week trial of hypertonic saline in children with mild cystic fibrosis lung disease: Effect on mucociliary clearance and clinical outcomes.
    Donaldson SH; Danielle Samulski T; LaFave C; Zeman K; Wu J; Trimble A; Ceppe A; Bennett WD; Davis SD
    J Cyst Fibros; 2020 Nov; 19(6):942-948. PubMed ID: 32669217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring airway surface liquid in cystic fibrosis.
    Ratjen F
    N Engl J Med; 2006 Jan; 354(3):291-3. PubMed ID: 16421371
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
    Mortensen J; Hansen A; Falk M; Nielsen IK; Groth S
    Chest; 1993 Mar; 103(3):805-11. PubMed ID: 8095449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2003; (1):CD001506. PubMed ID: 12535409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects.
    Daviskas E; Anderson SD; Gonda I; Eberl S; Meikle S; Seale JP; Bautovich G
    Eur Respir J; 1996 Apr; 9(4):725-32. PubMed ID: 8726937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ratjen F; Davis SD; Stanojevic S; Kronmal RA; Hinckley Stukovsky KD; Jorgensen N; Rosenfeld M;
    Lancet Respir Med; 2019 Sep; 7(9):802-809. PubMed ID: 31178421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.